Skip to main content
Table of Contents
Print

How Many PTSD Patients Use Medical Cannabis Regularly? 

Author: Dr. Clarissa Morton, PharmD

Recent surveys show that PTSD and cannabis use statistics point to a growing number of patients turning to cannabis for symptom relief. Many report using it several times per week, with some adopting daily use to manage anxiety, nightmares, and hyperarousal. 

While traditional treatments remain the first recommendation, cannabis is increasingly being recognised as a complementary tool. These usage rates in trauma patients reflect the rising demand for alternative therapies that address both emotional and physical challenges of PTSD. 

What The Numbers Suggest 

Data on cannabis use in PTSD continues to expand as more studies are carried out. Below are some insights from current findings. 

Prevalence Across Patient Groups 

Research indicates a steady increase in cannabis adoption for trauma-related care. The prevalence of cannabis in PTSD varies across regions, but the trend is consistently upward. 

Frequency Of Use 

Some patients report occasional use for acute symptoms, while others rely on regular intake. These differences shape overall medical marijuana frequency patterns within PTSD populations. 

Links To Symptom Management 

Higher use is often associated with attempts to control recurring nightmares and persistent anxiety. This connection reinforces the importance of understanding PTSD and cannabis use statistics in long-term treatment planning. 

Although more detailed research is still required, current findings suggest cannabis is becoming a central part of many patients’ coping strategies. For some, PTSD and cannabis use statistics highlight a growing shift toward integrating cannabis into daily routines for relief and recovery. 

Visit providers like LeafEase for personalised consultations that explore safe and structured approaches to cannabis use in PTSD care. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Post-Traumatic Stress Disorder (PTSD).

Dr. Clarissa Morton, PharmD
Author

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Categories